De novo expression of the Muc2 gene in pancreas carcinoma cells is triggered by promoter demethylation

Tumor Biology

Volumn 23, Issue 1, 2002, Pages 54-60

  Siedow, A ^a   Szyf, M ^c   Gratchev, A ^a   Kobalz, U ^a   Hanski, M L ^a   Bumke Vogt, C ^a   Foss, H D ^b   Riecken, E O ^a   Hanski, C ^a,b  

^a FREIE UNIVERSITÄT BERLIN   (Germany)

^b CHARITÉ UNIVERSITÄTSMEDIZIN BERLIN   (Germany)

^c MCGILL UNIVERSITY   (Canada)

Author keywords

DNA methylation; Intraductal mucinous pancreatic carcinoma; MUC2 gene regulation

Indexed keywords

5 AZA 2' DEOXYCYTIDINE; MUCIN 2;

ARTICLE; CANCER CELL CULTURE; CARCINOMA CELL; CONTROLLED STUDY; DEMETHYLATION; DNA METHYLATION; HUMAN; HUMAN CELL; MUCINOUS CARCINOMA; PANCREAS CARCINOMA; PAPILLARY CARCINOMA; PRIORITY JOURNAL; PROGNOSIS; PROTEIN EXPRESSION;

EID: 0036121135     PISSN: 10104283     EISSN: None     Source Type: Journal    
DOI: 10.1159/000048689     Document Type: Article

References (30)

1. Exocrine pancreatic tumours and their histological classification. A study based on 167 autopsy and 97 surgical cases
2. Resected adenocarcinoma of the pancreas - 616 Patients: Results, outcomes, and prognostic indicators
3. Cancer of the pancreas. 50 years of surgery
4. An introduction to mucin-producing tumors of the pancreas: Why they deserve more attention
5. Mucin hypersecreting neoplasms
6. Pancreatic tumors with cystic dilatation of the ducts: Intraductal papillary mucinous neoplasms and intraductal oncocytic papillary neoplasms
7. Intraductal papillary-mucinous tumors of the pancreas
8. Mucinous cystic neoplasms of the pancreas
9. MUC2 gene expression is found in noninvasive tumors but not in invasive tumors of the pancreas and liver: Its close relationship with prognosis of the patients
10. Colloid (mucinous noncystic) carcinomas of the pancreas
11. Overexpression or ectopic expression of MUC2 is the common property of mucinous carcinomas of the colon, pancreas, breast, and ovary
12. MUC2 gene suppression in human colorectal carcinomas and their metastases: In vitro evidence of the modulatory role of DNA methylation
13. Molecular cloning of human intestinal mucin cDNAs. Sequence analysis and evidence for genetic polymorphism
14. Differential gene expression in colon carcinoma cells and tissues detected with a cDNA array
15. A modified and improved method for bisulphite based cytosine methylation analysis
16. Rapid quantitation of methylation differences at specific sites using methylation-sensitive single nucleotide primer extension (Ms-SNuPE)
17. Correct evaluation of reporter assays in different cell lines by direct determination of the introduced plasmid amount
18. Identification and characterization of the MUC2 (human intestinal mucin) gene 5′-flanking region: Promoter activity in cultured cells
19. DNA methylation: Past, present and future directions
20. CpG methylation is maintained in human cancer cells lacking DNMT1
21. Expression of the MAGE-1 tumor antigen is up-regulated by the demethylating agent 5-aza-2′-deoxycytidine
22. The activation of human gene MAGE-1 in tumor cells is correlated with genome-wide demethylation
23. Identification of HLA-A2-restricted epitopes of the tumor-associated antigen MUC2 recognized by human cytotoxic T cells
24. Regulation of the intestinal mucin MUC2 gene expression in vivo: Evidence for the role of promoter methylation
25. Abrogation of the Rb/p16 tumor-suppressive pathway in virtually all pancreatic carcinomas
26. Differential mRNA expression of the human DNA methyltransferases (DNMTs) 1. 3a and 3b during the G(0)/G(1) to S phase transition in normal and tumor cells
27. DNA methyltransferase levels in tumorigenic and nontumorigenic cells in culture
28. High expression of the DNA methyltransferase gene characterizes human neoplastic cells and progression stages of colon cancer
29. Increased cytosine DNA-methyltransferase activity during colon cancer progression